belimumab
pharmaceutical drug
Facts
14 properties- Subclass of
- chemical compound
- Has use
- medication[5]
- Active ingredient in
- Benlysta[13]
- Defined daily dose
- 25 mg[14]
- Has characteristic
- biopharmaceutical[7]
- LiverTox likelihood score
- LiverTox toxicity likelihood category E[16]
- Medical condition treated
- lupus nephritis[8]
- Physically interacts with
- TNF superfamily member 13b[4]
- Pregnancy category
- US pregnancy category C[12]
- Route of administration
- intravenous injection[6]
- Subject has role
- immunosuppressive drug, monoclonal antibody[10][11]
- Trading name
- Benlysta[15]
- World Health Organisation international non-proprietary name
- belimumab[9]
🏷️ Also known as
en belimumab
en LymphoStat-B
en Lymphostat-B Benlysta
ar بيليموماب
fa mohamad
pt Benlysta
pt LymphoStat-B
ru Белимумаб
zh 贝利尤单抗
zh 贝利木单抗
🔖 Identifiers · 21
- OpenAlex ID
- C2781205201
- ATC code
- L04AA26
- CAS Registry Number
- 356547-88-1
- ChEMBL ID
- CHEMBL1789843
- DrugBank ID
- DB08879
- Encyclopedia of China (Third Edition) ID (2026)
- SztIm
- Encyclopedia of China (Third Edition) old ID (2021)
- 632926
- Freebase ID
- /m/027yjt9
- Guide to Pharmacology Ligand ID
- 6887
- KBpedia ID
- Belimumab
- KEGG ID
- D03068
- LiverTox ID
- Belimumab
Show all 21 identifiers +9
- MeSH descriptor ID
- C511911
- MedlinePlus drug identifier
- a611027
- Microsoft Academic ID (discontinued)
- 2781205201
- NDF-RT ID
- N0000182640
- PatientsLikeMe treatment ID
- belimumab
- RxNorm CUI
- 1092437
- UNII
- 73B0K5S26A
- WikiProjectMed ID
- Belimumab
- World Health Organisation international non-proprietary name numeric ID
- 8381
🔗 Connections
Subject has role 2
Has characteristic 1
Has use 1
Instance of 1
Medical condition treated 1
Physically interacts with 1
Route of administration 1
Subclass of 1
← Drug or therapy used for treatment 1
← Physically interacts with 1
Press Enter · cited answer in seconds